Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment 2024-11-26 08:44
GC Biopharma and Novelty Nobility Enter into Joint Research and Development Agreement for Geographic Atrophy Therapies 2024-10-29 09:13
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA 2024-09-03 15:59
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group 2024-06-20 08:44
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A 2024-06-10 16:18
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings 2024-06-04 13:00
GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor 2024-05-28 23:00
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance 2024-05-21 15:12
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval 2024-05-20 14:07
GC Cell to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 2024-04-02 23:00
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj. 2024-02-26 21:30
GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024 2024-02-14 16:33
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A) 2024-01-23 11:53
GC Cell's Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform 2024-01-09 00:00
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) 2023-12-18 09:49
GC Biopharma's groundbreaking for the plasma fractionation plant in Indonesia 2023-12-06 08:56
GC Biopharma establishes mRNA production facility in Hwasun, Korea 2023-12-01 16:31
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval 2023-11-06 09:11
GC Biopharma Shares its Successful HR System Transformation at SAP Success Connect 2023 2023-10-11 08:49
GC Biopharma Signs Power Purchase Agreement with SK E&S 2023-10-10 14:20
1 2 3